Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis
- 1 April 1998
- journal article
- review article
- Published by Elsevier in Atherosclerosis
- Vol. 137, S33-S38
- https://doi.org/10.1016/s0021-9150(97)00305-5
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- 17β-Estradiol and Smooth Muscle Cell Proliferation in Aortic Cells of Male and Female RatsBiochemical and Biophysical Research Communications, 1996
- High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion MoleculesArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- The Kuopio Atherosclerosis Prevention Study (KAPS): Effect of pravastatin treatment on lipids, oxidation resistance of lipoprotems, and atherosclerotic progressionThe American Journal of Cardiology, 1995
- Lowering of HDL 2b by Probucol Partly Explains the Failure of the Drug to Affect Femoral Atherosclerosis in Subjects With HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Estrogen modulates the inducible expression of platelet-derived growth factor mrna by monocyte/macrophagesLife Sciences, 1995
- The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)The American Journal of Cardiology, 1994
- Oxidized lipoproteins inhibit endothelium-dependent vasodilation. Effects of pressure and high-density lipoprotein.Hypertension, 1994
- Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content.Heart, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986